Disclosing genetic risk for Alzheimer's dementia to individuals with mild cognitive impairment

INTRODUCTION: The safety of predicting conversion from mild cognitive impairment (MCI) to Alzheimer's disease (AD) dementia using apolipoprotein E (APOE) genotyping is unknown. METHODS: We randomized 114 individuals with MCI to receive estimates of 3‐year risk of conversion to AD dementia infor...

Descripción completa

Detalles Bibliográficos
Autores principales: Christensen, Kurt D., Karlawish, Jason, Roberts, J. Scott, Uhlmann, Wendy R., Harkins, Kristin, Wood, Elisabeth M., Obisesan, Thomas O., Le, Lan Q., Cupples, L. Adrienne, Zoltick, Emilie S., Johnson, Megan S., Bradbury, Margaret K., Waterston, Leo B., Chen, Clara A., Feldman, Sara, Perry, Denise L., Green, Robert C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087414/
https://www.ncbi.nlm.nih.gov/pubmed/32211507
http://dx.doi.org/10.1002/trc2.12002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087414/
https://www.ncbi.nlm.nih.gov/pubmed/32211507
http://dx.doi.org/10.1002/trc2.12002

Ejemplares similares